Understanding the complex pharmacological changes that occur with ageing is critical to informed prescribing, yet much of today's practice in geriatric prescribing continues to be based on anecdotal evidence and case report data instead of controlled research studies. Navigating the vast database in geriatric psychopharmacology is a daunting task at best, leaving many clinicians overwhelmed and confused, and opening the door to potentially dangerous consequences for some of the most fragile patients. In this text, three experienced pharmacologists provide a practical "how to" guide to clinical geriatric prescribing, drawing upon their own first-hand clinical experience and their reading of the literature in geriatric psychopharmacology.
Rezensionen / Stimmen
"This book is a first rate guide to the drug treatment of psychiatric disorders of the elderly. It combines scientific principles and sound clinical advice. It is chock-full of clinical pearls that will be of interest to all physicians treating elderly patients." - Michael F. Folstein, M.D., Chairman and Professor, Department of Psychiatry, Tufts University School of Medicine; Psychiatrist-in-Chief, New England Medical Center
Sprache
Verlagsort
Verlagsgruppe
American Psychiatric Association Publishing
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Maße
Höhe: 210 mm
Breite: 133 mm
ISBN-13
978-0-88048-823-5 (9780880488235)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Introduction to geriatric psychopharmacology: pharmacokinetics and aging; pharmacodynamic changes with aging; the practice of geriatric psychopharmacology. Antipsychotics: pharmacokinetics of antipsychotics; pharmacodynamics and mechanism of antipsychotics; antipsychotic drug interactions; indications for antipsychotic use; efficacy of antipsychotics; clinical use of antipsychotics; side effects of antipsychotics; antipsychotic treatment of selected syndromes and disorders; antipsychotics - specific drugs. Antidepressants: pharmacokinetics of antidepressants; pharmacodynamics and mechanism of antidepressants; antidepressant drug interactions; efficacy of antidepressants; clinical use of antidepressants; side effects of antidepressants; antidepressant treatment of selected syndromes and disorders; antidepressants - specific drugs. Mood stabilizers: pharmacokinetics of mood stabilizers; pharmacodynamics and mechanism of mood stabilizers; mood stabilizer drug interactions; efficacy of mood stabilizers; clinical use of mood stabilizers; side effects of mood stabilizers; treatment of selected syndromes and disorders with mood stabilizers; mood stabilizers - specific drugs. Anxiolytic and sedative-hypnotic medications: pharmacokinetics of benzodiazepines; pharmacodynamics and mechanism of benzodiazepines; benzodiazepine drug interactions; indications for anxiolytic/sedative hypnotic use; efficacy of anxiolytic and sedative-hypnotic drugs; clinical use of anxiolytic and sedative-hypnotics; side effects of anxiolytic and sedative-hypnotic drugs; treatment of selected syndromes and disorders with anxiolytic and sedative-hypnotics; anxiolytic and sedative-hypnotic - specific drugs. Treatment of substance related disorders: substance use disorders; substance-induced disorders. Treatment of movement disorders: abnormalities of movement; treatment of selected movement disorders. Treatment of dementias and other cognitive syndromes: evaluation of the cognitively impaired elder; treatment of specific cognitive disorders; treatment of behavioural disturbances in dementia; dementias and other cognitive syndromes - specific drugs.
